Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2865407 | The American Journal of the Medical Sciences | 2007 | 9 Pages |
Abstract
Although the available comparative trials provide considerable evidence for the role of albendazole in patients with CE, there are some important clinical questions that remained unanswered by the studies. One of them is whether the combination of albendazole with praziquantel is superior to albendazole alone when both effectiveness and drug toxicity are taken into account. Also, further studies should also compare the combination of albendazole/PAIR with albendazole/surgery focusing on both short and long term outcomes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Matthew E. MD, MSc, DSc, Ioannis A. MD,